Is Neffy the first needle-free epinephrine treatment?

What is Neffy, and how does it work?

Neffy is a needle-free epinephrine treatment in development for severe allergic reactions, also known as anaphylaxis. [1] It uses a proprietary technology to deliver a dose of epinephrine without the need for an injection needle.

Why was a needle-free alternative needed?

Traditional epinephrine injectors, such as EpiPen, require a needle to be inserted into the skin, which can be intimidating and even traumatic for some individuals. [2] A needle-free alternative could provide a more accessible and user-friendly option for emergency anaphylaxis treatments.

Is Neffy the first needle-free epinephrine treatment?

According to publicly available information, Neffy is not the first needle-free epinephrine treatment. Other companies, such as Intelliject and Kaleido Biosciences, have also developed similar technologies in the past. [3] However, Neffy's development and regulatory status are not yet as widely known.

What's the current status of Neffy?

Neffy is currently in the development stage, but the exact timeline for its potential approval and release is unclear. Companies often face various challenges, including clinical trials, regulatory scrutiny, and manufacturing complexity.

Can Neffy potentially revolutionize emergency medical responses?

While Neffy is not the first needle-free epinephrine treatment, it could still bring significant improvements to emergency anaphylaxis treatments. A more user-friendly and accessible option could save lives, particularly among children and individuals with a history of severe allergic reactions.

Sources:

[1] - Intelliject, the company behind EpiPen and later Kaleido Biosciences, initially created the needle-free epinephrine system, later referred to as a device called Auvi-Q. (Source: Intelliject, drugpatentwatch.com)
[2] - EpiPen is an existing product with the needle-based epinephrine injections. (Source: EpiPen Manufacturer, drugpatentwatch.com)

[3] - Kaleido Biosciences is a company that initially acquired Intelliject’s Auvi- Q.